{"disease":{"id":"adhd","name":"adhd"},"drugs":{"marketed":[{"drug_id":"lisdexamfetamine","indication_name":"Attention Deficit Hyperactivity Disorder (ADHD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Vyvanse","generic_name":"LISDEXAMFETAMINE","company_name":"Takeda","drug_phase":"marketed","molecular_target":"Sodium-dependent dopamine transporter","drug_class":"Central Nervous System Stimulant","quality_score":80,"revenue":"3200","mechanism":"Vyvanse works by blocking the dopamine transporter, allowing more dopamine to be available in the brain."},{"drug_id":"viloxazine-hydrochloride","indication_name":"Treatment of ADHD","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"VILOXAZINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"dextroamphetamine-sulfate","indication_name":"Attention Deficit Hyperactivity Disorder (ADHD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DEXTROAMPHETAMINE SULFATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"dextroamphetamine","indication_name":"Attention Deficit Hyperactivity Disorder (ADHD)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"DEXTROAMPHETAMINE","company_name":"","drug_phase":"marketed","molecular_target":"Dopamine transporter (DAT), Norepinephrine transporter (NET)","drug_class":"Central nervous system stimulant","quality_score":10,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06115200","title":"Norwegian Adult Mental Health Registry","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150000,"lead_sponsor_name":"Helse Stavanger HF","has_results":false},{"nct_id":"NCT06155201","title":"Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders","phase":"NA","overall_status":"UNKNOWN","enrollment_count":12000,"lead_sponsor_name":"Chen Li","has_results":false},{"nct_id":"NCT05231902","title":"Prevalence of Attention Deficit/Hyperactivity Disorder and Parenting Stress in School-age Children in Chongqing, China","phase":"","overall_status":"UNKNOWN","enrollment_count":6480,"lead_sponsor_name":"Chen Li","has_results":false},{"nct_id":"NCT06169709","title":"An Online Survey for Women With Attention Deficit Hyperactivity Disorder (ADHD)","phase":"","overall_status":"COMPLETED","enrollment_count":5893,"lead_sponsor_name":"Parnassia Groep","has_results":false},{"nct_id":"NCT05870605","title":"Drug Use Study With Intuniv® in European Countries","phase":"","overall_status":"COMPLETED","enrollment_count":5000,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT00046059","title":"Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)","phase":"","overall_status":"COMPLETED","enrollment_count":3481,"lead_sponsor_name":"National Human Genome Research Institute (NHGRI)","has_results":false},{"nct_id":"NCT05137704","title":"A Study on the Use of Healthcare Resources and Costs of Attention Deficit Hyperactivity Disorder (ADHD) in Adults in England","phase":"","overall_status":"COMPLETED","enrollment_count":2236,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT06025890","title":"Clinical Evaluation and Intervention of Developmental Behavioral Diseases Based on Multicenter Cohort Study(CEIDBDBMCS)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2100,"lead_sponsor_name":"Chen Li","has_results":false},{"nct_id":"NCT06668519","title":"Magnetoencephalography in Children","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Children's Hospital of Fudan University","has_results":false},{"nct_id":"NCT04091633","title":"School Health Implementation Network: Eastern Mediterranean","phase":"NA","overall_status":"COMPLETED","enrollment_count":971,"lead_sponsor_name":"Human Development Research Foundation, Pakistan","has_results":false},{"nct_id":"NCT04095377","title":"Development of Automated Analysis to Electroencephelogram (EEG) Data in Patients Treated at the Sagol Hyperbaric Medicine and Research Center at the Years 2017-2019.","phase":"","overall_status":"COMPLETED","enrollment_count":875,"lead_sponsor_name":"QuantalX Neuroscience","has_results":false},{"nct_id":"NCT06457256","title":"Hybrid Effectiveness-Implementation Trial of a School Clinician Training and Psychosocial ADHD/ODD Intervention Program Adapted for Schools Across Mexico","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":872,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT05518435","title":"Managing Young People With ADHD in Primary Care Study","phase":"","overall_status":"COMPLETED","enrollment_count":816,"lead_sponsor_name":"University of Exeter","has_results":false},{"nct_id":"NCT07316387","title":"Neurobehavioral Development in Toddlers and Preschoolers in Relation to Prenatal Exposure of Mild Analgesics (NeuroToP - a COPANA Follow up)","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":685,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT06978452","title":"Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories","phase":"","overall_status":"RECRUITING","enrollment_count":560,"lead_sponsor_name":"Douglas Mental Health University Institute","has_results":false},{"nct_id":"NCT05296473","title":"Guided ADHD Therapy for Managing the Extent and Severity of Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":560,"lead_sponsor_name":"Lumos Labs, Inc.","has_results":false},{"nct_id":"NCT04087850","title":"Encouraging Social Inclusiveness as a Means to Improving Academic Performance","phase":"NA","overall_status":"COMPLETED","enrollment_count":558,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT05972044","title":"A Study to Assess the Efficacy and Safety of Solriamfetol in Subjects With ADHD (FOCUS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":516,"lead_sponsor_name":"Axsome Therapeutics, Inc.","has_results":false},{"nct_id":"NCT05048186","title":"Refining the Shared Decision Making Process Survey in ADHD Medication Decisions","phase":"","overall_status":"COMPLETED","enrollment_count":512,"lead_sponsor_name":"Massachusetts General Hospital","has_results":true},{"nct_id":"NCT04284059","title":"Adjuvant Effects of Vitamin A and Vitamin D Supplementation on Treatment of Children With ADHD","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":504,"lead_sponsor_name":"Chen Li","has_results":false},{"nct_id":"NCT04504474","title":"Network Analysis of Adult MDD and ADHD","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Health Sciences North Research Institute","has_results":false},{"nct_id":"NCT05916339","title":"AWARE: Management of ADHD in Autism Spectrum Disorder","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Daniel Coury","has_results":false},{"nct_id":"NCT03247530","title":"Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":477,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT00734578","title":"Efficacy and Safety of SPD503 in Combination With Psychostimulants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":461,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT03502239","title":"Cognitive Rehabilitation (Mega Team) and Its Effects on Emotional and Behavioral Regulation in ADHD, ASD, and CHD","phase":"NA","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"The Hospital for Sick Children","has_results":false},{"nct_id":"NCT05620745","title":"Comparison of Resilience Between ADHD and Controls.","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT06221358","title":"Pharmacogenomics of Stimulant Treatment Response","phase":"","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT04016779","title":"Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":374,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02396576","title":"Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas","phase":"NA","overall_status":"COMPLETED","enrollment_count":359,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT03080259","title":"Primary Care Prevention of Stimulant Diversion by High School Students With ADHD","phase":"NA","overall_status":"COMPLETED","enrollment_count":357,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT06808555","title":"Pai.ACT: AI-Driven ACT Chatbot for Mental Health Triage and Service Evaluation","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":340,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT06038942","title":"Formal Versus Informal Mindfulness Among University Students With Self-reported ADHD, Nonsuicidal Self-injury, or Stress","phase":"NA","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"McGill University","has_results":false},{"nct_id":"NCT00763971","title":"Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":336,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT06854601","title":"Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":333,"lead_sponsor_name":"Pharmasoft","has_results":true},{"nct_id":"NCT02618408","title":"Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":333,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02986672","title":"Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)","phase":"NA","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"University Hospital of North Norway","has_results":false},{"nct_id":"NCT00507065","title":"Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":329,"lead_sponsor_name":"Shire","has_results":false},{"nct_id":"NCT07381855","title":"Biosignatures for the Development of Attention Deficit Hyperactivity Disorder","phase":"NA","overall_status":"COMPLETED","enrollment_count":323,"lead_sponsor_name":"Florida International University","has_results":false},{"nct_id":"NCT04890717","title":"Biomarkers for Autism and ADHD in Children","phase":"","overall_status":"UNKNOWN","enrollment_count":320,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT00500071","title":"Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHD","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":318,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT06973577","title":"P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":315,"lead_sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","has_results":false},{"nct_id":"NCT00735371","title":"Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT01328756","title":"Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT03247543","title":"Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":313,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT05927506","title":"Adolescent Changes in Brain and Behavior in Boys and Girls With ADHD","phase":"","overall_status":"COMPLETED","enrollment_count":312,"lead_sponsor_name":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","has_results":false},{"nct_id":"NCT03247517","title":"Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":310,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04082234","title":"Reducing Disparities in Behavioral Health Treatment for Children in Primary Care","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Children's Hospital of Philadelphia","has_results":false},{"nct_id":"NCT03247556","title":"Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":297,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT02618434","title":"Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":297,"lead_sponsor_name":"Supernus Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT07262853","title":"Dual Executive Function Training Package","phase":"NA","overall_status":"RECRUITING","enrollment_count":288,"lead_sponsor_name":"Education University of Hong Kong","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}